Clinical trial · Interventional
Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
Health-related Quality of Life of Patients With Esophageal Cancer After Surgery in China: A Prospective Cohort Study From Multi-center
NCT01349517CI-TRIAL-00005761unknownPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this multi-center prospective cohort study is to study the health-related quality of life (HRQL) together with other outcomes of patients with esophageal cancer after surgery in China.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ivor-Lewis esophagectomy | Procedure | — | UNRESOLVED |
| MIE | Procedure | — | UNRESOLVED |
| Sweet esophagectomy | Procedure | — | UNRESOLVED |
| Three-incision thoracotomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- OTHER
- label
- MIE Group
- description
- The patients in this group would perform minimal invasive three-incision subtotal esophagectomy (thoracoscopic and/or laparoscopic)
- interventionNames
- Procedure: MIE
- type
- OTHER
- label
- Three-incision esophagectomy group
- description
- The patients in this group would perform three-incision subtotal esophagectomy (thoracotomy and laparotomy)
- interventionNames
- Procedure: Three-incision thoracotomy
- type
- OTHER
- label
- Ivor-Lewis esophagectomy group
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 35 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical stage I/II esophageal cancer * Normal blood test of basic metabolism panel * Pulmonary function: FEV1 \> 1.2L, FEV1% \> 50%, DLCO \> 50% * Heart function: NY grade I and grade II Exclusion Criteria: * Mental disorders * Combination with other cancers * With a previous history of thoracic or ventral surgery
References
Publications (0)
Data not yet available
No reference posted for this study.